Skip to content
SentinelMarket desk
Switch to dark mode

아이엠비디엑스

461030KOSDAQView the 바이오 R&D sectorTheme Bio & healthcare

2,655KRWMarket close of 10/20 (Tue)

Up +1.92%+50KRWMarket close of 10/20 (Tue)

Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/21 (Wed)2,550KRWDown -3.95%

Preliminary · just after the close · replaced by official KRX data tomorrow morning

Open
2,605
High
2,755
Low
2,595
Day range
Day range low 2,595 high 2,755, open 2,605, close 2,655, previous close 2,605
Volume
1×10K shares
16.57 million KRW 0.30× the 20-session average

Market close of 10/20 (Tue)

Where it sits in the 1-year range

1-year close range 2,460 to 12,080 won, 2% up from the low

2% of the way up from the lowest close in 1 year (252 sessions) · -78.0% from the high

Usual range

Nothing unusual in the 3 checked items

Free · no sign-inSource from 2021-05-17

Points to check

  • Earningsnot verifiedOutside financial data coverage, so not verified
  • Recent filingsnot verifiedOutside filing data coverage, so not verified
  • Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified

The other 3 are within the usual range

  • Daily move+1.92%usual range
  • Trading value0.3×usual range
  • Data date10/20 (Tue)Market close
See the full check report

Same sector · 바이오 R&D

Down -2.19%

· 16 of 64 stocks up, preferred shares excluded · trading value 190.5B KRW

Same sector · top by trading value
Stock20DChangeTrading value
알테오젠Close over the last 20 sessions -9.6%Down -3.35%51.1B KRW
올릭스Close over the last 20 sessions -12.2%Down -4.03%19.1B KRW
디앤디파마텍Close over the last 20 sessions -11.8%Down -1.93%15.1B KRW
리가켐바이오Close over the last 20 sessions -15.4%Down -1.41%12.1B KRW
프로티나Close over the last 20 sessions +31.8%Up +7.38%10.0B KRW

Schedule

  • Next data 10/22 (Thu) after 08:50

Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 81% of trading value, about 92% of market capitalisation. Coverage status →

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.